People: Concert Pharmaceuticals Inc (CNCE.OQ)
18 Apr 2019
Dr. Ronald W. Barrett, Ph.D., is an Independent Director of Concert Pharmaceuticals Inc. Dr. Barrett is the Director of the company. Dr. Barrett has served as a member of our board of directors since December 2007. Dr. Barrett is a founder of XenoPort, Inc., a public biopharmaceutical company, and has served as its Chief Executive Officer since 2001, its Chief Scientific Officer from 1999 to 2001 and as a member of its board of directors since 1999. Prior to XenoPort he held various positions at Affymax Research Institute, a drug discovery company now owned by GlaxoSmithKline plc, and Abbott Laboratories, a healthcare company. Dr. Barrett received a B.S. from Bucknell University and a Ph.D. in pharmacology from Rutgers University. We believe that Dr. Barrett’s industry and board experience, including his experience as the chief executive officer of a publically traded biopharmaceutical company, makes him a key contributor to our board of directors.
|Total Annual Compensation, USD||47,720|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||90,720|
|Fiscal Year Total, USD||138,440|